ESTUDIO CLINICO DEL EFECTO HIPOLIPEMIANTE DEL ACETATO DE FENOXITETRALINA (CH13437) = ETUDE CLINIQUE DES EFFETS HYPOLIPEMIANTS DE L'ACETATE DE PHENOXYTETRALINE (CH13437)1970; REV. MED. HOSP. COLONIA; MEX.; DA. 1970; VOL. 18; NO 104; PP. 133-136; BIBL. 6REF.Serial Issue

CLOFIBRATE AND NAFENOPIN (SU-13437): EFFECTS ON PLASMA CLEARANCE AND TISSUE DISTRIBUTION OF CHYLOMICRON TRIGLYCERIDE IN THE DOG = CLOFIBRATE ET NAFENOPINE (SU 13437): EFFETS SUR LA CLEARANCE PLASMATIQUE ET LA REPARTITION TISSULAIRE DE TRIGLYCERIDES DES CHYLOMICRONS CHEZ LE CHIENCENEDELLA RJ.1972; LIPIDS; U.S.A.; DA. 1972; VOL. 7; NO 10; PP. 644-652; BIBL. 28 REF.Serial Issue

PLASMA ENDOGENOUS TRIGLYCERIDE TRANSPORT IN HYPERTRIGLYCERIDEMIA AND EFFECT OF A HYPOLIPIDAEMIC DRUG (SU-13437) = TRANSPORT DES TRIGLYCERIDES PLASMATIQUES ENDOGENES EN CAS D'HYPERTRIGLYCERIDEMIE ET ACTION D'UN MEDICAMENT HYPOLIPIDEMIQUE (SU 13437)NIKKILAE EA; KEKKI M.1972; EUROP. J. CLIN. INVEST.; GERM.; DA. 1972; VOL. 2; NO 4; PP. 231-238; BIBL. 1P.1/2Serial Issue

TREATMENT OF PRIMARY HYPERLIPOPROTEINAEMIAS WITH A TETRALIN DERIVATIVE (SU-13437) = TRAITEMENT DES HYPERLIPOPROTEINEMIES PRIMITIVES PAR UN DERIVE DE LA TETRALINE (SU-13437)FELLIN R; FEDELE D; BAGNARIOL G et al.1973; ATHEROSCLEROSIS; NETHERL.; DA. 1973; VOL. 17; NO 3; PP. 383-388; BIBL. 9REF.Serial Issue

COMPARATIVE STUDIES ON THE ACTION OF THE OPTICAL ANTIPODES OF THE HYPOPOLIPIDAEMIC ARYLOXYALKANOIC ACID CH 13.437, ON LIVER ENZYMES OF THE RAT = ETUDES COMPARATIVES SUR L'ACTION DES ANTIPODES OPTIQUES DE L'ACIDE ARYLOXYALCANOIQUE HYPOLIPIDEMIQUE: CH 13.437 SUR LES ENZYMES HEPATIQUES DU RATSCHACHT U; SCHMITT K; GRANZER E et al.1972; EXPERIENTIA; SUISSE; DA. 1972; VOL. 29; NO 7; PP. 788-790; ABS. ALLEM.; BIBL. 18REF.Serial Issue

EFFECT OF NAFENOPIN (SU-13, 437) ON LIVER FUNCTION. INFLUENCE ON THE HEPATIC TRANSPORT OF ORGANIC ANIONS.MEIJER DKF; BOGNACKI J; LEVINE WG et al.1975; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1975; VOL. 290; NO 2-3; PP. 235-250; BIBL. 2 P.Article

EFFECT OF NAFENOPIN (SU-13,437) ON LIVER FUNCTION HEPATIC UPTAKE AND BILIARY EXCRETION OF OUABAIN IN THE RATMEIJER DKF; BOGNACKI J; LEVINE WG et al.1975; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1975; VOL. 3; NO 3; PP. 220-225; BIBL. 18REF.Article

EFFECT OF NAFENOPIN (SU-13,437) ON LIVER FUNCTION. MECHANISM OF CHOLERETIC EFFECT.LEVINE WG; BRAUNSTEIN IR; MEIJER DKF et al.1975; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1975; VOL. 290; NO 2-3; PP. 221-234; BIBL. 19 REF.Article

TRATTAMENTO DELLE IPERLIPIDEMIE PRIMITIVE CON UN TETRALIN-DERIVATO = TRAITEMENT DES HYPERLIPIDEMIES PRIMITIVES AU MOYEN D'UN DERIVE DE TETRALINEFELLIN R; FEDELE D; BAGNARIOL G et al.1972; G. ITAL. CARDIOL.; ITAL.; DA. 1972; VOL. 2; NO 6A; PP. 863-870; ABS. ANGL.; BIBL. 14 REF.Serial Issue

INCREASED HEPATOTOXICITY OF CARBON TETRACHLORIDE BY THE HYPOLIPIDEMIC DRUG NAFENOPIN IN RATSCHARPENTIER D; TUCHWEBER B.1982; RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY; ISSN 0034-5164; USA; DA. 1982; VOL. 36; NO 3; PP. 449-461; BIBL. 17 REF.Article

COMPARATIVE STUDY OF SEVERAL HYPOLIPIDEMIC AGENTS RELATED TO CLOFIBRATE = ETUDE COMPARATIVE DE PLUSIEURS AGENTS HYPOLIPIDEMIANTS APPARENTES AU CLOFIBRATEBEAUMONT V; BUXTORF JC; JACOTOT B et al.1974; ATHEROSCLEROSIS; NETHERL.; DA. 1974; VOL. 20; NO 2; PP. 141-153; BIBL. 1P.1/2Article

AZIONE DELL'ACIDO 2-METIL-2-(4-(1,2,3,4-TETRAIODO-1-NAFTIL) FENOSSI) PROPIONICO (SU 13437) SULLE FRAZIONI LIPIDICHE, SULLA FIBRINOLISI E SULL'AGGREGAZIONE PIASTRINICA IN CONIGLI CON IPERCOLESTERINEMIA SPERIMENTALE = ACTION DE L'ACIDE METHYL-2 ((TETRAIODO-1,2,3,4 NAPHTYL-1)-4 PHENOXY)-2 PROPIONIQUE (SU-13437) SUR LES FRACTIONS LIPIDIQUES, SUR LA FIBRINOLYSE ET L'AGREGATION PLAQUETTAIRE CHEZ DES LAPINS AVEC UNE HYPERCHOLESTEROLEMIE EXPERIMENTALEGIAROLA P; EGGE H; GIBELLI A et al.1974; FARMACO, ED. PRAT.; ITAL.; DA. 1974; VOL. 29; NO 8; PP. 463-468; ABS. ANGL.; BIBL. 17 REF.Article

LIPOPROTEINES DU SERUM ET MEDICAMENTS HYPOLIPIDEMIANTS APPARENTES AU CLOFIBRATEBEAUMONT JL; DACHET C.1973; ATHEROSCLEROSIS; NETHERL.; DA. 1973; VOL. 17; NO 3; PP. 419-433; ABS. ANGL.; BIBL. 10REF.Serial Issue

INCREASE IN HEPATIC CARNITINE ACETYLTRANSFERASE ACTIVITY ASSOCIATED WITH PEROXISOMAL (MICROBODY) PROLIFERATION INDUCED BY THE HYPOLIPIDEMIC DRUGS CLOFIBRATE, NAFENOPIN, AND METHYL CLOFENAPATE = AUGMENTATION DE L'ACTIVITE CARNITINE ACETYLTRANSFERASIQUE HEPATIQUE LIEE A LA PROLIFERATION DE PEROXYSOMES (MICROBODY) INDUITE PAR LES PRODUITS HYPOLIPIDEMIANTS CLOFIBRATE, NAFENOPINE ET CLOFENAPATE DE METHYLEMOODY DE; REDDY JK.1974; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 9; NO 3; PP. 501-510; BIBL. 2P.Article

EFFECT OF NAFENOPIN (SU-13437) ON LIVER FUNCTION. INFLUENCE ON THE HEPATIC TRANSPORT OF PHENOLPHTHALEIN GLUCURONIDE AND CHLOROTHIAZIDEUESUGI T; LEVINE WG.1976; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1976; VOL. 4; NO 2; PP. 107-111; BIBL. 18 REF.Article

STUDIES ON THE HEPATOMEGALY CAUSED BY THE HYPOLIPIDEMIC DRUGS NAFENOPIN AND CLOFIBRATE. = ETUDE DE L'HEPATOMEGALIE PROVOQUEE PAR LES HYPOLIPEMIANTS, NAFENOPINE ET CLOFIBRATEBECKETT RB; WEISS R; STITZEL RE et al.1972; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1972; VOL. 23; NO 1; PP. 42-53; BIBL. 1P.Serial Issue

HEPATOCELLULAR CARCINOMAS IN ACATALASEMIC MICE TREATED WITH NAFENOPIN, A HYPOLIPIDEMIC PEROXISOME PROLIFERATORREDDY JK; SAMBASIVA RAO M; MOODY DE et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 4; PP. 1211-1217; BIBL. 22 REF.Article

BILIARY EXCRETION OF 3,4-BENZPYRENE IN NAFENOPIN-TREATED RATSLEVINE WG; BOGNACKI J.1976; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1976; VOL. 196; NO 2; PP. 486-492; BIBL. 33 REF.Article

EFFECTS OF THE HYPOLIPIDEMIC DRUG NAFENOPIN ON THE ZONA FASCICULATA OF THE RAT ADRENAL CORTEX: A CORRELATED BIOCHEMICAL AND STEREOLOGICAL STUDYMAZZOCCHI G; ROBBA C; REBUFFAT P et al.1982; ANATOMICAL RECORD; ISSN 0003-276X; USA; DA. 1982; VOL. 204; NO 3; PP. 245-254; BIBL. 2 P.Article

EFFECT OF THE HYPOLIPIDEMIC DRUG NAFENOPIN (2-METHYL-2(P-(1,2,3,4-TETRAHYDRO-1-NAPHTHYL)-PHENOXY)PROPIONIC ACID; TPIA, SU-13,437) ON THE HEPATIC DISPOSITION OF FOREIGN COMPOUNDS IN THE RAT = EFFET DU MEDICAMENT HYPOLIPIDEMIQUE NAFENOPINE: ACIDE (METHYL-2((P-TETRAHYDRO-1,2,3,4 NAPHTYL-1)PHENOXY)-2 PROPIONIQUE: TPIA, SU-13437) SUR LE METABOLISME HEPATIQUE DES COMPOSES ETRANGERS CHEZ LE RATLEVINE WG.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 2; PP. 178-186; BIBL. 39REF.Article

Microcystin-LR and liver tumor promotion : Effects on cytokinesis, ploidy, and apoptosis in cultured hepatocytesHUMPAGE, A. R; FALCONER, I. R.Environmental toxicology. 1999, Vol 14, Num 1, pp 61-75, issn 1520-4081Article

In vitro covalent binding of nafenopin-CoA to human liver proteinsSALLUSTIO, B. C; NUNTHASOMBOON, S; DROGEMULLER, C. J et al.Toxicology and applied pharmacology. 2000, Vol 163, Num 2, pp 176-182, issn 0041-008XArticle

Reduced expression of mature TGFβ1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopinSTRANGE, J; ROBERTS, R. A.Mutation research. 1996, Vol 372, Num 1, pp 107-113, issn 0027-5107Article

Induction of cytosolic and microsomal epoxide hydrolases by the hypolipidaemic compound nafenopin in the mouse liverWAECHTER, F; BIERI, F; STAUBLI, W et al.Biochemical pharmacology. 1984, Vol 33, Num 1, pp 31-34, issn 0006-2952Article

The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscleMACDONALD, R. S; SWAN, P. B.Biochimica et biophysica acta. 1986, Vol 880, Num 2-3, pp 153-160, issn 0006-3002Article